Moderna sues Pfizer for mRNA Patent Infringement: when optics and profits reveal real issues in modern IP law usage
IPilogue
NOVEMBER 3, 2022
Moderna and Pfizer battle’s over the inventive process of their respective mRNA COVID-19 vaccines revisit the negative associations of profit, monopolies, and optics in patent litigation. A statutory defense to patent enforcement could be another solution, as seen in the American approach in 28 U.S. Code § 1498 (a).
Let's personalize your content